Ligand Pharmaceuticals Inc.

06/09/2025 | Press release | Distributed by Public on 06/09/2025 14:04

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.
The 2025 Annual Meeting of the Stockholders of Ligand Pharmaceuticals Incorporated (the "Company") was held on June 6, 2025 (the "Annual Meeting"). Set forth below are the final voting results for the actions taken by the stockholders at the Annual Meeting.
Proposal 1. The election of eight members of the Board of Directors of the Company for terms expiring at the 2026 annual meeting of stockholders. In accordance with the results below, each nominee was elected to serve as a director of the Company.
Votes For
Votes Withheld
Broker Non-Votes
Jason M. Aryeh
13,595,137
3,224,879
1,363,582
Todd C. Davis
16,393,716
426,300
1,363,582
Nancy R. Gray, Ph.D.
16,470,033
349,983
1,363,582
Jason Haas
16,621,292
198,724
1,363,582
John W. Kozarich, Ph.D.
15,684,962
1,135,054
1,363,582
John L. LaMattina, Ph.D.
15,961,637
858,379
1,363,582
Stephen L. Sabba, M.D.
15,789,883
1,030,133
1,363,582
Martine Zimmermann, Pharm.D.
16,666,655
153,361
1,363,582
Proposal 2.The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. In accordance with the results below, the selection of Ernst & Young LLP was ratified.
Votes For
Votes Against
Abstentions
Broker Non-Votes
17,274,429
906,847
2,322
-
Proposal 3.The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved.
Votes For
Votes Against
Abstentions
Broker Non-Votes
15,576,200
1,183,843
59,973
1,363,582
Ligand Pharmaceuticals Inc. published this content on June 09, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 09, 2025 at 20:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io